Medical monitoring system
The wireless medical monitoring system addresses the challenge of non-compliance by classifying therapy efficacy and providing feedback, enhancing treatment efficiency and compliance through data-driven notifications and context-aware adaptations.
Patent Information
- Application Number
- PCT/EP2024/063089
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-06-14
- Filing Date
- 2024-05-13
- Publication Date
- 2024-11-28
AI Technical Summary
Current medical treatment environments face challenges in reliably determining the efficacy of therapies due to patient non-compliance, leading to inefficient treatment outcomes.
A wireless medical monitoring system that receives physiologic data from sensors, classifies therapy efficacy, and generates notifications to improve compliance and adapt therapy as needed, using a method that includes identifying patients, associating context information, and employing different wireless communication techniques for efficient data transmission.
Enhances the reliability and efficiency of monitoring therapy efficacy, reduces false adaptations, and increases patient compliance by providing timely feedback and reminders, thereby improving treatment outcomes.
Smart Images

Figure EP2024063089_28112024_PF_FP_ABST
Abstract
Description
[0001] Medical Monitoring System
[0002] The present invention relates to wireless communication within a medical monitoring system to determine efficacy of a patient therapy, compliance of the patient with respect to the therapy and to provide corresponding feedback.
[0003] Today’s medical treatment environment is a complex one, composed of multiple types of sensors (e.g., wearable or implanted), wearable or implantable devices, patient symptoms, clinical signs, and an array of other inputs. The vast majority of medical therapies is dominated by oral medications, with additional prescriptive treatments including changes in lifestyle (e.g., change of diet or increase of sport activities), reduction of risk factors (e.g., less smoking), and other behavioral modifications. Unfortunately, these prescriptive treatments including medications can be impacted severely by low compliance by the patient. As a result, it is difficult to reliably determine the efficacy of therapies which may lead to inefficient treatment of patients.
[0004] In view of these drawbacks, there is a need for an efficient and reliable way of monitoring the therapy of a patient. In particular, with respect to the efficacy of the therapy and a compliant performing of the therapy.
[0005] This need is at least partially met by the method, device, system and computer program of the present invention.
[0006] A 1staspect of the present invention refers to a method for wireless communication at a recipient device within a medical monitoring system, the method comprising the steps of: receiving physiologic data associated with a patient from at least one sensor within the medical monitoring system; classifying an efficacy of a therapy of the patient based at least in part on the physiologic data; and generating a notification based at least in part on the efficacy of the therapy.
[0007] According to a 2ndaspect, the method further comprises: transmitting the notification to one or more processing units within the medical monitoring system; and / or outputting the notification on the recipient device.
[0008] Providing a method which classifies the efficacy of a patient therapy based on the physiologic data associated with the patient and generates a corresponding notification allows for an efficient monitoring of the therapy and provides the possibility for an early adaption of the therapy if necessary. Regular notifications may also increase the compliance with the therapy, because simple and careless mistakes such as forgetting the intake of the medication are reduced. The method may also include deciding, e.g. by the recipient device, at least in part based on the notification, e.g. its priority, to which one or more processing units it may be transmitted. For example, a notification with low priority may only go to the patient, while an urgent message (e.g. emergency state) may go (additionally) to the health care system or an emergency management system, e.g. at a doctor and / or a hospital.
[0009] According to a 3rdaspect, the method further comprises: obtaining identification information of the patient; and associating the identification information with the therapy of the patient. The identification information may for example be received from the at least one sensor within the medical monitoring system.
[0010] According to a 4thaspect, obtaining the identification information of the patient comprises: receiving an identifier of the at least one sensor and determining the identification information of the patient based on the identifier; or receiving an encrypted identifier of the patient (110) and decrypting the encrypted identifier to obtain the identification information of the patient. Providing the identification information of the patient to associate the correct therapy increases the reliability of the monitoring and potential adaptions of the therapy (in accordance with ISO 14708-2: 13.3).
[0011] According to a 5thaspect, the method further comprises: classifying the efficacy of the therapy as effective and wherein the notification indicates the therapy being effective; or classifying the efficacy of the therapy as partially effective and wherein the notification indicates at least one therapy parameter which does not fulfill a predefined target and / or a recommendation for an adaption of the therapy; or classifying the therapy as ineffective and wherein the notification indicates a required therapy change and / or an emergency state of the patient.
[0012] Providing a fine-granular classification scheme for the efficacy of the therapy allows to efficiently monitor and adapt the therapy of the patient resulting in an improved treatment.
[0013] According to a 6thaspect, the method further comprises: accessing context information about the patient; and wherein classifying the efficacy of the therapy is further based on the context information.
[0014] According to a 7thaspect, the context information includes: a voice command given by the patient; location information of the patient; therapy protocol information; and / or a ratio between time spent upright and supine.
[0015] According to an 8thaspect, the method further comprises: determining based on the context information whether a behavior of the patient is compliant or deviant with actions as defined by the therapy; and if the behavior is deviant: classifying the efficacy of the therapy as non-assessable and wherein the notification indicates a reminder to actions restoring a compliant behavior.
[0016] Considering additional context information for the classification of the efficacy allows to determine whether the patient’s behavior is compliant with the therapy. Thus, false adaption of the therapy due to apparently low efficacy while the real reason lies in the non- compliance of the patient, can be avoided. Instead, a reminder for the patient may be generated.
[0017] A 9thaspect of the present invention refers to a recipient device comprising means to perform any of the methods as described herein.
[0018] For example, a recipient device may be provided for wireless communication within a medical monitoring system. The recipient device may comprise means for receiving physiologic data associated with a patient from at least one sensor within the medical monitoring system. It may further comprise means for classifying an efficacy of a therapy of the patient based at least in part on the physiologic data. Still further, it may comprise means for generating a notification based at least in part on the efficacy of the therapy.
[0019] A 10thaspect of the present invention refers to a medical monitoring system comprising: one or more sensors associated with a patient; a recipient device as described herein; and wherein each sensor is configured to collect physiologic data of the patient and transmit the physiology data to the recipient device.
[0020] According to an 11thaspect, the medical monitoring system further comprises one or more processing units; wherein each processing unit comprises means to receive a notification from the recipient device.
[0021] According to a 12thaspect, the medical monitoring system further comprises a relay device, wherein the relay device is configured to: receive the physiologic data from the one or more sensors using a first type of wireless communication technique; and transmitting the physiologic data to the recipient device using a second type of wireless communication technique.
[0022] Using a relay device capable of different types of wireless communication techniques increases the efficiency and reliability of the communication, because certain techniques may be better suited for certain types of sensors. For example, it may be that communication between near-field devices is better supported by one type of communication scheme while communication between a device and a broader network is better supported by another, different type of communication scheme.
[0023] According to a 13thaspect, the physiologic data as described herein comprises at least one of: electrocardiogram, ECG, parameters; blood pressure; blood oxygen saturation; activity / motion data; respiration activity; thoracic impedance; temperature; galvanic skin resistance; photoplethysmogram, PPG; pulse pressure; and / or cardiac information including: statistics from a cardiac device of the patient; a pacing threshold; sensing amplitudes; percent of cardiac pacing in a left heart chamber of the patient; percent of cardiac pacing in a right hear chamber of the patient; pacing sequences; pacing rates; atrioventricular delay; a PR interval of a heartbeat of the patient; a QT interval of a heartbeat of the patient; a QRS interval of a heartbeat of the patient; morphology changes of QRS and / or ECG; timing of activity between heart chambers of the patient; properties of ectopic beats and / or arrythmias. Activity / motion data may be accelerometer-generated data indicative of whether or not the patient is moving, stationary, exercising vigorously, or otherwise.
[0024] According to a 14thaspect, the one or more sensors as descried herein are implanted into the patient and / or applied to the patient.
[0025] A 15thaspect of the present invention refers to a computer program comprising instructions, which when executed by a computer, causes the computer to perform the methods as described herein.
[0026] It is noted that all methods described herein may include features even if they are rather described with reference to a device, system or computer program. Vice versa, aspects that may be described herein with reference to a method may as well be implemented as a corresponding function of a device, system or computer program.
[0027] Whether described as method steps, computer program and / or means, the functions described herein may be implemented in hardware, software, firmware, and / or combinations thereof. If implemented in software / firmware, the functions may be stored on or transmitted as one or more instructions or code on a computer-readable medium.
[0028] Computer-readable media include both computer storage media and communication media including any medium that facilitates transfer of a computer program from one place to another. A storage medium may be any available media that can be accessed by a general purpose or special purpose computer. By way of example, and not limitation, such computer-readable storage media can comprise RAM, ROM, EEPROM, FPGA, CD / DVD or other optical disk storage, magnetic disk storage or other magnetic storage devices, or any other medium that can be used to carry or store desired program code means in the form of instructions or data structures and that can be accessed by a general -purpose or special-purpose computer, or a general-purpose or special-purpose processor.
[0029] The methods as described herein may also be implemented in hardware, software, firmware, and / or combinations thereof, for example, by means of one or more general- purpose or special-purpose computers, and / or a general-purpose or special-purpose processors.
[0030] The following figure is provided to support the understanding of the present invention.
[0031] Fig. 1 Illustration of a medical monitoring system according to aspects of the present invention.
[0032] The following detailed description outlines possible exemplary implementations of the present invention.
[0033] Fig 1 illustrates a medical monitoring system (100) according to aspects of the present invention. The medical monitoring system (MMS) (100) may monitor a patient (110) for example regarding a therapy, an efficacy of the therapy, a compliance of a behavior of the patient with respect to the therapy and / or a health state of the patient (e.g., health state is stable, improves, worsens, emergency state etc.). The MMS (100) may monitor specific organs of the patient (110) such as heart and / or lungs. The MMS (100) may comprise a recipient device (120) (e.g., a mobile device such as a smartphone, smart watch or laptop, or a stationary device such as a (cloud-) server). The MMS (100) may comprise one or more (physiological) sensors (140a; 140n). The one or more sensors (140a; 140n) may collect (i.e., each sensor may be configured to collect) physiologic data associated with the patient 110.
[0034] A sensor may be attached to (e.g., a health tracker, smart watch or a sensor connected to an implanted device etc.) or implanted into the patient 110. A sensor may comprise or be connected to means (e.g., processing module, storage means, transmission means) to process, store and / or transmit data. A sensor may for example collect the physiologic data from an implanted (medical) device such as a cardiac monitor, heart monitor (ICM), implantable pulse generator (IPG), an implantable device monitoring respiration activity. The one or more sensors (140a; 140n) may transmit the collected data directly to the recipient device (120) or may transmit the collected data to a relay device (150), which then transmits the data to the recipient device (120). In the latter case, the relay device 150 may be configured to receive the (physiologic) data from the one or more sensors (140a; 140n) using a first type of wireless communication technique (e.g., Bluetooth low energy, radio frequency, conducted pulses within and / or throughout a body part of the patient 110, e.g. MICS, and / or ultrasound, acoustic or telemetric communication) and transmit the (physiologic) data to the recipient device (120) using a second type of wireless communication technique (e.g., WiFi or cellular communications such as 4G, 5G etc.). The relay device 150 may be a mobile device or a corresponding apparatus (e.g., a chip, a transceiver etc.) at a patient device.
[0035] The physiologic data may comprise electrocardiogram (ECG) parameters, blood pressure, blood oxygen saturation, respiration activity, thoracic impedance, temperature, galvanic skin resistance, PPG, pulse pressure, and / or cardiac information including statistics from a cardiac device of the patient 110, a pacing threshold, sensing amplitudes, percent of cardiac pacing in a left heart chamber of the patient (110), percent of cardiac pacing in a right heart chamber of the patient (110), pacing sequences, pacing rates; atrioventricular delay, a PR interval of a heartbeat of the patient (110), a QT interval of a heartbeat of the patient (110), a QRS interval of a heartbeat of the patient (110), morphology changes of QRS and / or ECG, timing of (electrical or mechanical) activity between heart chambers of the patient (110), properties of ectopic beats and / or arrythmias.
[0036] The MMS (100) may comprise one or more processing units (130a;130n;130'a;130'n). Some of the processing units (130'a;130'n) may be associated with the patient (110) such as a mobile device of the patient (110). Some of the processing units (130a; 130n) may be associated with caregivers, physicians, hospitals or the corresponding health care system which are responsible for the therapy of the patient (110). Each processing unit (130a;130n;130'a;130'n) may comprise means to receive a notification from the recipient device (120).
[0037] The recipient device (120) may receive the physiologic data associated with a patient (110) (i.e., the physiologic data is collected from the patient) from at least one sensor (140a; 140n) within the MMS (100), may classify an efficacy of a therapy of the patient (110) based at least in part on the physiologic data and may generate a notification based at least in part on the efficacy of the therapy. The generated notification may be transmitted to the one or more processing units (130a;130n;130'a;130'n) within the MMS (110). The generated notification may be outputted on the recipient device (120) (e.g., the notification may be displayed on a display of the recipient device or may issue a vibration of the recipient device). The recipient device (120) may identify the therapy of the patient 110 for example by accessing a corresponding database comprising a look up table storing a mapping between the patient (110) and one or more therapies of the patient (110). In order to enable the identifying, the recipient device (120) may obtain identification information of the patient (110) and associate the identification information with the therapy of the patient (110).
[0038] Obtaining the identification information of the patient (110) may comprise receiving an identifier (e.g., MAC ID or sensor device ID) of the at least one sensor (140a; 140n) or the corresponding monitoring device (e.g., implanted medical device) and determining the identification information of the patient (110) based on the identifier. In this example, the recipient device (120) may access a mapping between the identifier of the at least one sensor (140a; 140n) and a corresponding therapy. For example, the MAC ID may allow to obtain the identification information without requiring stored personal information of the patient (e.g., a patient ID, name etc.). In case the patient (110) is undergoing multiple therapies and each therapy is monitored by different sensor(s) (140a; 140n), corresponding sensor / device IDs may be used to map and identify the correct therapies. For example, assume the recipient device (120) receives a first identifier of a first sensor (140a; 140n) and a second identifier of a second sensor (140a; 140n). The recipient device may first verify if both (the first and the second) identifiers are part of the same mapping (e.g., look up table). This way it is ensured that the corresponding physiologic data received via the two sensors (140a; 140n) belongs to the same patient (110). Afterwards, it is checked whether both sensors (140a; 140n) provide data relevant to the same and / or different therapies. The sensor identifier may be encrypted and decrypted (e.g., using AES) at the recipient device 120 before further processing it as described above.
[0039] Obtaining the identification information of the patient (110) may also comprise receiving an encrypted identifier of the patient (110) and decrypting the encrypted identifier to obtain the identification information of the patient (HO). The identifier of the patient (110) may be encrypted and decrypted (e.g., using AES). This way, the reliability of the association between patient (100) and therapy may be improved compared to the approach based on the sensor identifier. However, this approach may require a higher security standard due to rules regarding personal data privacy. It may thus also be possible to combine both approaches for example depending on a severity of the therapy of the patient (110). For example, a first therapy for slight overweight may have a low severity, because the corresponding sensor(s) (140a; 140n) may merely collect data relating to for example steps of the patient (110). In contrast, a second therapy for a cardiac disease may have a high severity, because the corresponding sensor(s) (140a; 140n) may collect sensitive data such as ECG parameters of the patient (110). Accordingly, the first therapy may be monitored using the approach based on the identifier of the sensor (140a; 140n) and the second therapy may be monitored using the approach based on the encrypted identifier of the patient (110). The efficacy of the therapy may be classified by the recipient device (120) as either effective, partially effective, ineffective and in case additional context information is accessible as non-assessable. The classification may be done using a trained model and / or other types and forms of artificial intelligence (Al). The trained model may be a deep learning model such as a neural network, or a machine learning model such as decisions trees or the like.
[0040] If classified as effective, the generated notification may indicate the therapy as being effective. If classified as partially effective, the generated notification may indicate at least one therapy parameter which does not fulfill a predefined target and / or a recommendation for an adaptation of the therapy. If classified as ineffective, the notification may indicate a required therapy change and / or an emergency state of the patient 110. Based on the classification result, a corresponding recommendation model may provide respective recommendations for adapting the therapy or a therapy change. Additionally, the current health state of the patient (110) may be assessed based on the available information (sensor and / or context information). Based on the health state the content of the notification as well as the selection of the processing units (130a;130n;130'a;130'n) to which the notification is transmitted, may be determined. Additionally, a future development of the health state based on the current health state may be predicted. Accordingly, content of the notification as well as the selection of the processing units 130a;130n;130'a;130'n to which the notification is transmitted may be determined. For example, if a health state of the patient 110 is urgent (i.e., an emergency state) the notification may be handled as an urgent / high priority notification and may be transmitted to the processing unit (130a; 130n) of an emergency management system. A low priority notification (e.g., a reminder to walk a certain amount of steps or a reminder to provide a daily weighting information) may only be transmitted to the patient 110.
[0041] The recipient device (120) may access the context information for example by obtaining the context information from a database, by requesting the context information from another source (e.g., one of the one or more processing units (130a;130n;130'a;130'n)) or by receiving the context information from the patient (110) (e.g., from one of the one or more sensors (140a; 140n)). Accordingly, the classification of the efficacy of the therapy may further be based on the context information. The context information may include a voice command (given by the patient (110)) or further voice analytics, location information of the patient (110), therapy protocol information and / or a ratio between time spent upright and supine. The location information may relate to current or past movement patterns of the patient (110) allowing inferences about behavioral characteristics of the patient (110), movement data of the patient (110), geolocation information etc. The therapy protocol information may relate to protocol information about the therapy either manually entered by the patient (110) or other entities (e.g., caregivers, physicians or respective institutions such as hospitals or other therapy related locations) involved in the therapy of the patient (110) or automatically generated protocol information (e.g., information from an electronic pill box which indicates whether the box has been opened or not which provides information about the patient 110 acting compliant regarding the medication of the therapy). Based on the context information it may be determined whether a behavior of the patient 110 is compliant or deviant with actions as defined by the therapy and if the behavior is deviant, the efficacy of the therapy may be classified as non-assessable, and the notification may indicate a reminder to actions restoring a compliant behavior.
[0042] In a first illustrative example, data from an implantable device such as a cardiac monitor or implantable pulse generator system is collected, and the therapy relates to corresponding medication. In this example, a drug such as a beta blocker may be utilized to reduce a (high) heart rate (e.g., resulting from an overactive sympathetic nervous system in the context of a heart failure) and to reduce unexpected increases in the heart rate of the patient (110) which would be detrimental for the patient (110). The recipient device (120) may for example receive data relating to an observed resting rate. In case, the resting rate increases beyond a given threshold (e.g., 85 beats per minute), it is determined that the beta blocker may not be effective or only partially effective. As a result, a notification may be generated and transmitted for example to a physician indicating that the beta blocker is ineffective or partially effective. The physician may then either adapt the therapy (e.g., by increasing the dose) or change the therapy (e.g., using another type of beta blocker). However, if corresponding context information is available which indicates that the beta blocker was not taken (correctly) by the patient (e.g., provided by an electronic pill box), the efficacy of the therapy may be classified as non-assessable. The generated notification may then indicate a reminder for the patient 110 to actions restoring a compliant behavior (i.e., a reminder to take the beta blocker).
[0043] In a second illustrative example, the SpO2 or oxygen saturation is monitored by a sensor of a wearable device and a sensor of an implantable device likewise monitors respiration activity. When an anomaly in respiration activity occurs, coupled with a drop in SpO2, and an increase in heart rate is measured by either the sensor of the wearable or the implantable device, it is determined that sleep apnea is occurring. Accordingly, the corresponding therapy for example a CPAP machine may be classified as partially effective and a notification is generated which indicates potential adaptions of the therapy (e.g., modifying the settings of the CPAP machine) to restore the efficacy of the therapy.
[0044] In a third illustrative example, a heart failure patient (110) is being monitored using physiologic and context (e.g., behavioral statistics) information. For instance, thoracic impedance, respiration rates, frequency of atrial fibrillation and duration of atrial fibrillation episodes, numbers of ectopic beats such as PVCS, and pulmonary artery pressure are measured along with additional sensor data such as PPG, and GPS or Geo location data indicating that the patient (110) is no longer moving or physically active. Based thereon, a potential for an acute or near future heart failure may be detected. Accordingly, the current therapy may be classified inefficient. Thus, a notification indicating the emergency state of the patient (110) may be generated and transmitted to the processing unit (130a; 13 On) of a caregiver as well as to the processing unit (130a; 13 On) of an emergency ambulance. The notification may also indicate to the patient 110 or the caregiver to increase the dosage of the prescribed diuretic.
[0045] In a fourth illustrative example, a patient (110) is prescribed an antiviral medication due to an infection. One known side effect of antiviral medications is prolongation of the QT interval. Prolongation of the QT interval can increase the risk of sudden cardiac death particularly in pronounced cases. The ECG parameters such as QT interval and the relevant rates providing a QTC measurement are constantly monitored by the MMS 100. When an increase in QTC is detected, the therapy is classified as partially effective or ineffective. Accordingly, a notification is generated indicating the patient (110) or the caregiver of the increased risk. Thus, titration of the medication or stoppage of the medication may be indicated by the notification before an adverse event occurs.
[0046] In a fifth illustrative example, a sensor (140a; 140n) of an implantable cardiac monitor recognizes an ST elevation associated with myocardial infarction in a patient (110). Because of the urgency and simplicity of this input signal, the sensor, the cardiac monitor, or a mobile device, immediately generates a notification for the patient 110. For instance, the patient's mobile device may display a warning with an audible tone or vibration to the patient (110) and may indicate to take an aspirin or other antiplatelet therapy. Simultaneously the notification may be sent other processing units (130a; 130n) within the MMS (100). This way the mobile device of the patient 110 acts as the recipient device (120) avoiding possible delays that may be incurred in case the recipient device (120) would be a remote cloud server.
[0047] The methods according to the present invention may be implemented in terms of a computer program which may be executed on any suitable data processing device comprising means (e.g., a memory and one or more processors operatively coupled to the memory) being configured accordingly. The computer program may be stored as computer-executable instructions on a non-transitory computer-readable medium.
[0048] Embodiments of the present disclosure may be realized in any of various forms. For example, in some embodiments, the present invention may be realized as a computer- implemented method, a computer-readable memory medium, or a computer system.
[0049] In some embodiments, a non-transitory computer-readable memory medium may be configured so that it stores program instructions and / or data, where the program instructions, if executed by a computer system, cause the computer system to perform a method, e.g., any of the method embodiments described herein, or, any combination of the method embodiments described herein, or, any subset of any of the method embodiments described herein, or, any combination of such subsets. In some embodiments, a computing device may be configured to include a processor (or a set of processors) and a memory medium, where the memory medium stores program instructions, where the processor is configured to read and execute the program instructions from the memory medium, where the program instructions are executable to implement any of the various method embodiments described herein (or, any combination of the method embodiments described herein, or, any subset of any of the method embodiments described herein, or, any combination of such subsets). The device may be realized in any of various forms.
[0050] Although specific embodiments have been described above, these embodiments are not intended to limit the scope of the present disclosure, even where only a single embodiment is described with respect to a particular feature. Examples of features provided in the disclosure are intended to be illustrative rather than restrictive unless stated otherwise. The above description is intended to cover such alternatives, modifications, and equivalents as would be apparent to a person skilled in the art having the benefit of this disclosure.
[0051] The scope of the present disclosure includes any feature or combination of features disclosed herein (either explicitly or implicitly), or any generalization thereof, whether or not it mitigates any or all of the problems addressed herein. In particular, with reference to the appended claims, features from dependent claims may be combined with those of the independent claims and features from respective independent claims may be combined in any appropriate manner and not merely in the specific combinations enumerated in the appended claims.
Claims
Claims1. A method for wireless communication at a recipient device (120) for use within a medical monitoring system (100), the method comprising the steps of: receiving physiologic data associated with a patient (110) from at least one sensor (140a; 140n) within the medical monitoring system (100); classifying an efficacy of a therapy of the patient (110) based at least in part on the physiologic data; and generating a notification based at least in part on the efficacy of the therapy.
2. The method of claim 1, further comprising transmitting the notification to one or more processing units (130a;130n;130'a;130'n) within the medical monitoring system (100); and / or outputting the notification on the recipient device (120).
3. The method of any one of the claims 1 or 2, wherein the method further comprises obtaining identification information of the patient (110); and associating the identification information with the therapy of the patient (110).
4. The method of claim 3, wherein obtaining the identification information of the patient (110) comprises receiving an identifier of the at least one sensor (140a; 140n) and determining the identification information of the patient (110) based on the identifier; or receiving an encrypted identifier of the patient (110) and decrypting the encrypted identifier to obtain the identification information of the patient (110).
5. The method of any one of the claims 1 to 4, wherein the method further comprises: classifying the efficacy of the therapy as effective and wherein the notification indicates the therapy being effective; or classifying the efficacy of the therapy as partially effective and wherein the notification indicates at least one therapy parameter which does not fulfill a predefined target and / or a recommendation for an adaption of the therapy; or classifying the therapy as ineffective and wherein the notification indicates a required therapy change and / or an emergency state of the patient (110).
6. The method of any one of the claims 1 to 5, wherein the method further comprises accessing context information about the patient (110); and wherein classifying the efficacy of the therapy is further based on the context information.
7. The method of claim 6, wherein the context information includes a voice command given by the patient (110); location information of the patient (110); therapy protocol information; and / or a ratio between time spent upright and supine.
8. The method of any one of the claims 6 or 7, wherein the method further comprises: determining, based on the context information, whether a behavior of the patient (110) is compliant or deviant with actions as defined by the therapy; and if the behavior is deviant: classifying the efficacy of the therapy as non-assessable and wherein the notification indicates a reminder to actions restoring a compliant behavior.
9. A recipient device (120) comprising means to perform the method of any one of the claims 1 to 8.
10. A medical monitoring system (100) comprising: one or more sensors (140a; 140n) associated with a patient (110); a recipient device (120) according to claim 9; and wherein the one or more sensors (140a; 140n) are configured to: collect physiologic data of the patient (110); and transmit the physiologic data to the recipient device (120).
11. The medical monitoring system (100) of claim 10, further comprising one or more processing units (130a;130n;130'a;130'n); and wherein each processing unit (130a;130n;130'a;130'n) comprises means to receive a notification from the recipient device (120).
12. The medical monitoring system (100) of any one of the claims 10 or 11, further comprising a relay device (150), wherein the relay device (150) is configured to: receive the physiologic data from the one or more sensors (140a; 140n) using a first type of wireless communication technique; and transmit the physiologic data to the recipient device (120) using a second type of wireless communication technique.
13. The method of any of claims 1 to 8, the recipient device (120) of claim 9, or the medical monitoring system (100) of any of claims 10 to 12, wherein the physiologic data comprises at least one of: electrocardiogram, ECG, parameters; blood pressure; blood oxygen saturation; activity / motion data; respiration activity; thoracic impedance; temperature; galvanic skin resistance; photoplethysmogram, PPG; pulse pressure; and / or cardiac information including: statistics from a cardiac device of the patient (110); a pacing threshold; sensing amplitudes; percent of cardiac pacing in a left heart chamber of the patient (110); percent of cardiac pacing in a right hear chamber of the patient (110); pacing sequences; pacing rates; atrioventricular delay; a PR interval of a heartbeat of the patient (110); a QT interval of a heartbeat of the patient (110); a QRS interval of a heartbeat of the patient (110); morphology changes of QRS and / or ECG; timing of activity between heart chambers of the patient (110); properties of ectopic beats and / or arrythmias.
14. The method of any of claims 1 to 8, the recipient device (120) of claim 9, or the medical monitoring system (100) of any of claims 10 to 12, wherein the one or more sensors (140a; 140n) are implanted into and / or applied to the patient (110).
15. A computer program comprising instructions, which when executed by a computer, causes the computer to perform the method of any one of the claims 1 to 8.
Citation Information
Patent Citations
Heart failure monitoring
US20120253207A1
Notification indicative of a change in efficacy of therapy
US20140213926A1
Evaluating drug efficacy by using wearable sensors
US20230068469A1
